AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
Currently predicting for Wed, 22 May 2024

Trading levels for RNXT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.46 4.28 %
R2 1.44 2.65 %
R1 1.42 1.64 %
Current price: 1.40
Support S1 1.38 -1.63 %
S2 1.36 -2.64 %
S3 1.34 -4.28 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.72 22.86 %
R2 1.69 20.71 %
R1 1.60 14.29 %
Current price 1.40
Support S1 1.32 -5.71%
S2 1.18 -15.71%
S3 1.17 -16.43%

RNXT Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About RenovoRx, Inc.

RenovoRx. RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.... RNXT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT